Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR-Expressing Metastatic Colorectal Cancer Following Failure of Standard Chemotherapy: A Phase II Single-Arm Prospective Study
Authors:
- 9 December 2019
- journal article
- research article
- Published by Springer Nature in Targeted Oncology
- Vol. 15 (1) , 67-73
Abstract
Despite new agents to treat metastatic colorectal cancer (CRC), patients eventually progress and additional therapies are needed.Keywords
This publication has 30 references indexed in Scilit:
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal CancerNew England Journal of Medicine, 2013
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trialThe Lancet, 2013
- Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in BXPC-3 and PANC-1 human pancreatic cancer cellsExperimental and Therapeutic Medicine, 2011
- Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2008
- Schedule-Dependent Cytotoxic Synergism of Pemetrexed and Erlotinib in Human Non–Small Cell Lung Cancer CellsClinical Cancer Research, 2007
- Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I–II studyAnnals of Oncology, 2007
- Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarrayVirchows Archiv, 2006
- Randomized Phase II Trial of the Clinical and Biological Effects of Two Dose Levels of Gefitinib in Patients With Recurrent Colorectal AdenocarcinomaJournal of Clinical Oncology, 2005
- Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinomaCancer, 2000
- EGF receptorThe International Journal of Biochemistry & Cell Biology, 1999